Showing posts with label Treatment. Show all posts
Showing posts with label Treatment. Show all posts

Friday, 25 November 2011

Tax Treatment of IP Holding Companies now available on CD

London, United Kingdom (PRWEB) October 10, 2011

Now available on CD a BNA webcast originally recorded 13th July 2011 in which leading tax professionals located in the United States, UK, Ireland, and Malta discuss the tax treatment of IP holding companies.


In Tax Treatment of IP Holding Companies, a panel of experts consider from the perspective of four different jurisdictions key issues including the taxation of royalty income, the comparison of the taxation of overseas IP with local IP, incentives for investment in IP, anti-deferral mechanisms and Transfer Pricing and IP.


The portability of intellectual property, for example, means that tax authorities are often concerned that profits can be artificially diverted outside the jurisdiction to reduce a group's tax burden. Yet the UK is introducing an exemption for IP holding companies with a limited UK connection and reviewing the anti-deferral mechanisms currently in place. Other jurisdictions are taking different approaches to the problem and the panel provides valuable insight into these approaches.


The panel also examines, from the perspective of their jurisdictions, the increasingly significant issue of transfer pricing and intellectual property, highlighting particular problems encountered in practice.


The panel of experts includes:


UK: Anne Fairpo, CTA(Fellow), Barrister, 13 Old Square Chambers & Atlas Chambers


Anne Fairpos practice covers UK and international corporate tax planning and disputes, acting for a range of clients from small owner-managed businesses to listed multinationals. Anne is the author of "Taxation of Intellectual Property" and contributes to a number of other publications. She is on the Council of the Chartered Institute of Taxation and chairs the Education Committee of the Institute.


Malta: Michael Ellul, Partner QUBE Services Limited/David Griscti & Associates


With extensive experience at PricewaterhouseCoopers, in 2006 Michael Ellul joined forces with David Griscti and Thomas Jacobsen to establish QUBE Services Limited. The joint organisation QUBE Services Limited/David Griscti & Associates is a market leader in the Investment Services (securities) market and in the area of tax planning and compliance and corporate services in Malta. QUBE Services Limited/David Griscti & Associates is based in the capital city, Valletta, and services an international client base on a multi-jurisdictional basis.


Ireland: Peter Maher, Partner, A&L Goodbody and is Head of the Firm's Tax Department


Peter Maher represents clients in every aspect of tax work, with particular emphasis on inbound investment, cross border financings and structuring, capital market transactions and US multinational tax planning and business restructurings. Peter is regularly listed as a leading adviser in Euromoneys Guide to the Worlds Leading Tax Lawyers, The Legal 500, Whos Who of International Tax Lawyers, Chambers Global and PLC Which Lawyer? 2011 and Who's Who Legal 2010 and 2011. He is a former Co-chair of the Taxes Committee of the International Bar Association and of the Irish Chapter of the International Fiscal Association.


United States: Rocco Femia, Member, Miller & Chevalier


Rocco Femias practice focuses on international tax planning for domestic and foreign-based enterprises, and on assisting such enterprises in avoiding or resolving controversies with the Internal Revenue Service (IRS) and foreign tax authorities involving U.S. international tax rules, transfer pricing, and U.S. tax treaties. Rocco has represented taxpayers before the IRS, the U.S. Department of the Treasury, the Joint Committee on Taxation, and the staffs of the House Ways and Means Committee and the Senate Finance Committee. Rocco has also advised governments on U.S. international tax developments.


Rocco is a former Associate International Tax Counsel at the U.S. Department of the Treasury, Office of Tax Policy.


Taxation of IP Holding Companies on CD is priced at

Rottenstein Law Group Marks Inefficacy of Vibration Treatment for Osteoporosis

New York, NY (PRWEB) November 21, 2011

According to a November 15 piece published by U.S. News and World Report, the treatment, which involves standing on a motorized, vibrating platform in the hope of building bone mass showed promise in animals. But researchers, who hoped those results might translate to humans, found no benefit for women who used the platforms for a year, according to study co-author Angela M. Cheung, an internist and director of the osteoporosis program at the University Health Network, University of Toronto, quoted in the piece.


The report notes that Dr. Joseph Lane, professor of orthopedic surgery at Weill Medical College of Cornell University, said the study appears valid and debunks the use of whole-body therapy to treat bone loss. Currently, he said, bisphosphonate medications such as Fosamax are the best initial treatment for bone loss.


But Fosamax is not without its own problems. Despite being the most popular osteoporosis treatment medication on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition where the jawbone dies due to a lack of blood supply. More recently, people have suffered low-impact femur fractures after falling from standing height or less. Evidence is building that taking Fosamax or similar medications for the treatment of osteoporosis causes a dramatic increase in risk of this particular kind of rare fracture to the thigh bone, all as reported by the New York Times.


As of June 30, 2011, according to Merck itself, approximately 1,650 cases, which include approximately 2,050 plaintiff groups, had been filed and were pending against Merck in either federal or state court. The Rottenstein Law Group urges anyone whose friend or relative has been prescribed Fosamax or another osteoporosis drug to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group maintains a Fosamax Femur Fracture Lawsuit Information Center at http://www.fosamaxfemurfracturelawsuit.com. The site has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about the dangers of Fosamax.


About THE ROTTENSTEIN LAW GROUP

The Rottenstein Law Group is a New York-based law firm that represents clients in dangerous drug lawsuits. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective consumer products. http://www.rotlaw.com


Contact:

The Rottenstein Law Group, LLP

Rochelle Rottenstein, Esq.

1259 Veeder Drive

Hewlett NY 11557

(212) 933-9500 (office phone)

(212) 933-9980 (facsimile)

rochelle(at)rotlaw(dot)com

http://www.rotlaw.com


###







Find More Facebook Press Releases